Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study - Yamaguchi, M; Kwong, Y L; Kim, W S (J Clin Oncol, 2011)
et al.